Skip to content

Effects of fatty acids on postprandial inflammatory response van healthy obese and type 2 diabetic obese subjects

Effects of fatty acids on postprandial inflammatory response van healthy obese and type 2 diabetic obese subjects - PIFA study (Study on Postprandial Inflammation and Fatty Acids)

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON33112
Enrollment
66
Registered
2009-07-03
Start date
2009-10-26
Completion date
Unknown
Last updated
2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obese en gezonde vrijwilligers the molecular and biochemical mechanism of fatty acids in blood cells

Interventions

Elke participant will consume 3 high-fat milkshakes differering in fatty acid composition (saturated fat, monounsaturated fat and polyunsaturated fat)

Sponsors

Wageningen Universiteit
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria for all participants: - male gender -50-70 yrs For diabetic patients only: - BMI >30 kg/m2 - Well-controlled diabetes: fasting plasma glucose concentration must be 30 kg/m2 - normoglycemic according to WHO criteria (OGTT, fasting blood glucose

Exclusion criteria

Exclusion criteria: Exclusion criteria for all participants: All subjects: - Female gender - Age below 50 or above 70 years - Hemoglobin levels 3 kg in the past three months) - Medical condition that can interfere with the study outcome (i.e. cardiovascular disease, gastrointestinal disease, renal dysfunction) - Use of medications know to interfere with glucose homeostasis (i.e. corticosteroids) - abuse of drugs and/or alcohol - participation in another biomedical study within 1 month before the first screening visit;For obese, type 2 diabetic subjects only: - severe diabetes which requires application of insulin - diabetes-related complications For obese subjects and lean controls only: - hyperglycemic according to WHO criteria (OGTT, fasting blood glucose >6.0mM, after 2 hr>11mM) -systolic blood pressure >160 mmHg or diastolic blood pressure > 100 mmHg - Urinary glucose concentrations (>0.25 g/l)

Design outcomes

Primary

MeasureTime frame
PBMC gene expression profiles

Secondary

MeasureTime frame
PBMC inflammatory response capacity Endothelial function Tertiar: lipid profiles plasma glucose and insulin monocyte and lymfocyte gene expression profiles

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)